Skip to main content

Cellebrite DI Ltd. (CLBT) Stock Analysis

Recovery setup

SellVALUE-TRAP 1/5Moderate Confidence

Technology · Software - Infrastructure

Sell if holding. Multiple concerning factors at $13.30: Leverage penalty (D/E 4.5): -1.5; Sector modifier (Technology): -0.8.

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt,... Read more

$13.30+28.0% A.UpsideScore 6.3/10#15 of 78 Software - Infrastructure
QualityF-score8 / 9FCF yield4.40%
Stop $12.52Target $17.23(analyst − 13%)A.R:R 2.0:1
Analyst target$19.80+48.9%5 analysts
$17.23our TP
$13.30price
$19.80mean
$23

Sell if holding. Multiple concerning factors at $13.30: Leverage penalty (D/E 4.5): -1.5; Sector modifier (Technology): -0.8. Chart setup: Death cross but MACD improving, RSI 57. Score 6.3/10, moderate confidence.

Passes 7/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 93d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

Recent Developments — Cellebrite DI Ltd.

Generated 2026-05-20T20:21:21Z.

Thesis

Rewards
Strong growth profile
Analyst upside: 28%
Risks
Sector modifier (Technology): -0.8
Leverage penalty (D/E 4.5): -1.5
Below 200-MA, MA slope -1.9%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)48.7
P/E (Fwd)20.7
Mkt Cap$3.4B
EV/EBITDA37.1
Profit Mgn14.5%
ROE16.4%
Rev Growth19.3%
Beta1.15
DividendNone
Rating analysts13

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.33bullish
IV76%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
2.4
Bollinger
3.0
52w Position
3.1
Gap
5.0
GatesDeath cross (50MA < 200MA)Momentum 6.5>=5.5A.R:R 2.0 ≥ 1.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 93d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
57 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $11.54Resistance $14.05

Price Targets

$13
$17
A.Upside+29.5%
A.R:R2.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Analyst Consensus

Analysts13
Consensus4.2/5
Avg Target$20

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-20 (93d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLBT stock a buy right now?

Sell if holding. Multiple concerning factors at $13.30: Leverage penalty (D/E 4.5): -1.5; Sector modifier (Technology): -0.8. Chart setup: Death cross but MACD improving, RSI 57. Prior stop was $12.52. Score 6.3/10, moderate confidence.

What is the CLBT stock price target?

Take-profit target: $17.23 (+28.0% upside). Prior stop was $12.52. Stop-loss: $12.52.

What are the risks of investing in CLBT?

Sector modifier (Technology): -0.8; Leverage penalty (D/E 4.5): -1.5; Below 200-MA, MA slope -1.9%/30d (confirmed downtrend).

Is CLBT overvalued or undervalued?

Cellebrite DI Ltd. trades at a P/E of 48.7 (forward 20.7). TrendMatrix value score: 6.1/10. Verdict: Sell.

What do analysts say about CLBT?

13 analysts cover CLBT with a consensus score of 4.2/5. Average price target: $20.

What does Cellebrite DI Ltd. do?Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East,...

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Related stocks: PICS (PicS N.V.) · DLO (DLocal Limited) · ZETA (Zeta Global Holdings Corp.) · CPAY (Corpay, Inc.) · GCT (GigaCloud Technology Inc)